Literature DB >> 1548075

Genetic evidence that bound coagulase of Staphylococcus aureus is not clumping factor.

D McDevitt1, P Vaudaux, T J Foster.   

Abstract

Staphylococcus aureus Newman cells carry a surface receptor for fibrinogen called clumping factor. The bacteria also express coagulase, an extracellular protein that binds to prothrombin to form a complex with thrombinlike activity which coverts fibrinogen to fibrin. We have confirmed a recent report (M. K. Bodén and J.-I. Flock, Infect. Immun. 57:2358-2363, 1989) that coagulase can bind to fibrinogen as well as to prothrombin and also that a fraction of coagulase is firmly attached to the cell. A mutant with a deletion in the chromosomal coa gene was isolated by allelic replacement. Allelic replacement either was directly selected by electrotransformation of S. aureus R3N4220 with a nonreplicating suicide plasmid, pCOA18, carrying the delta coa::Tcr mutation or occurred after transduction of the integrated pCOA18 plasmid. The coa mutant was completely devoid of coagulase activity but interacted both with soluble fibrinogen and with solid-phase fibrinogen with the same avidity as the parental strain. This strongly suggests that the bound form of coagulase is not clumping factor and is not responsible for the adherence of S. aureus Newman to solid-phase fibrinogen. The fibrinogen binding determinant of coagulase was located in the C terminus of the protein, by analyzing truncated fusion proteins, in contrast to the prothrombin-binding region which was located in the N terminus.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1548075      PMCID: PMC257025          DOI: 10.1128/iai.60.4.1514-1523.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  36 in total

1.  Colony hybridization: a method for the isolation of cloned DNAs that contain a specific gene.

Authors:  M Grunstein; D S Hogness
Journal:  Proc Natl Acad Sci U S A       Date:  1975-10       Impact factor: 11.205

2.  Evidence for two forms of staphylococcal coagulase.

Authors:  E S DUTHIE
Journal:  J Gen Microbiol       Date:  1954-06

3.  Staphylococcal coagulase; mode of action and antigenicity.

Authors:  E S DUTHIE; L L LORENZ
Journal:  J Gen Microbiol       Date:  1952-02

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Identification of a region of human fibrinogen interacting with staphylococcal clumping factor.

Authors:  J Hawiger; S Timmons; D D Strong; B A Cottrell; M Riley; R F Doolittle
Journal:  Biochemistry       Date:  1982-03-16       Impact factor: 3.162

6.  Isolation, characterization, and synthesis of peptides from human fibrinogen that block the staphylococcal clumping reaction and construction of a synthetic clumping particle.

Authors:  D D Strong; A P Laudano; J Hawiger; R F Doolittle
Journal:  Biochemistry       Date:  1982-03-16       Impact factor: 3.162

7.  A toxic shock syndrome toxin mutant of Staphylococcus aureus isolated by allelic replacement lacks virulence in a rabbit uterine model.

Authors:  R Sloane; J C de Azavedo; J P Arbuthnott; P J Hartigan; B Kreiswirth; R Novick; T J Foster
Journal:  FEMS Microbiol Lett       Date:  1991-03-01       Impact factor: 2.742

8.  Repression and catabolite repression of the lactose operon of Staphylococcus aureus.

Authors:  B Oskouian; G C Stewart
Journal:  J Bacteriol       Date:  1990-07       Impact factor: 3.490

9.  Activation of a pro-enzyme by a stoichiometric reaction with another protein. The reaction between prothrombin and staphylocoagulase.

Authors:  H C Hemker; B M Bas; A D Muller
Journal:  Biochim Biophys Acta       Date:  1975-01-30

10.  Enzymatic properties of staphylothrombin, an active molecular complex formed between staphylocoagulase and human prothrombin.

Authors:  S Kawabata; T Morita; S Iwanaga; H Igarashi
Journal:  J Biochem       Date:  1985-12       Impact factor: 3.387

View more
  37 in total

1.  Isolation and characterization of a sigB deletion mutant of Staphylococcus aureus.

Authors:  R O Nicholas; T Li; D McDevitt; A Marra; S Sucoloski; P L Demarsh; D R Gentry
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

2.  Influence of a functional sigB operon on the global regulators sar and agr in Staphylococcus aureus.

Authors:  M Bischoff; J M Entenza; P Giachino
Journal:  J Bacteriol       Date:  2001-09       Impact factor: 3.490

3.  Antibacterial action of extracellular mammalian group IIA phospholipase A2 against grossly clumped Staphylococcus aureus.

Authors:  M E Dominiecki; J Weiss
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

4.  Phase I dose escalation study to evaluate the safety and pharmacokinetic profile of tefibazumab in subjects with end-stage renal disease requiring hemodialysis.

Authors:  Seth Hetherington; Michele Texter; Eric Wenzel; Joseph M Patti; Laurie Reynolds; Trish Shamp; Suzanne Swan
Journal:  Antimicrob Agents Chemother       Date:  2006-10       Impact factor: 5.191

5.  Phase II, randomized, double-blind, multicenter study comparing the safety and pharmacokinetics of tefibazumab to placebo for treatment of Staphylococcus aureus bacteremia.

Authors:  J John Weems; James P Steinberg; Scott Filler; John W Baddley; G Ralph Corey; Priya Sampathkumar; Lisa Winston; Joseph F John; Christine J Kubin; Rohit Talwani; Thomas Moore; Joseph M Patti; Seth Hetherington; Michele Texter; Eric Wenzel; Violet A Kelley; Vance G Fowler
Journal:  Antimicrob Agents Chemother       Date:  2006-08       Impact factor: 5.191

6.  Influence of agr on fibrinogen binding in Staphylococcus aureus Newman.

Authors:  C Wolz; D McDevitt; T J Foster; A L Cheung
Journal:  Infect Immun       Date:  1996-08       Impact factor: 3.441

7.  Open-label, dose escalation study of the safety and pharmacokinetic profile of tefibazumab in healthy volunteers.

Authors:  Sandra Reilley; Eric Wenzel; Laurie Reynolds; Beth Bennett; Joseph M Patti; Seth Hetherington
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

8.  Role of Staphylococcus aureus coagulase and clumping factor in pathogenesis of experimental endocarditis.

Authors:  P Moreillon; J M Entenza; P Francioli; D McDevitt; T J Foster; P François; P Vaudaux
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

Review 9.  Staphylococcus aureus Aggregation and Coagulation Mechanisms, and Their Function in Host-Pathogen Interactions.

Authors:  H A Crosby; J Kwiecinski; A R Horswill
Journal:  Adv Appl Microbiol       Date:  2016-08-04       Impact factor: 5.086

10.  Functional blocking of Staphylococcus aureus adhesins following growth in ex vivo media.

Authors:  Ruth C Massey; Shobana R Dissanayeke; Brian Cameron; David Ferguson; Timothy J Foster; Sharon J Peacock
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.